Ganser A - Search Results

1

Colony-stimulating factors in the management of neutropenia and its complications.

Heuser M, Ganser A. Heuser M, et al. Among authors: ganser a. Ann Hematol. 2005 Oct;84(11):697-708. doi: 10.1007/s00277-005-1087-4. Epub 2005 Jul 27. Ann Hematol. 2005. PMID: 16047204 Review.

2

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Ganser A, Hoelzer D. Ganser A, et al. Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53. Hematol Oncol Clin North Am. 1992. PMID: 1377194 Review.

3

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.

4

In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.

Ganser A, Janssen JW, Ottmann OG, Seipelt G, Eder M, Becher R, Lindermann A, Herrmann F, Schulz G, Mertelsmann R, et al. Ganser A, et al. Leukemia. 1991 Jun;5(6):487-92. Leukemia. 1991. PMID: 1676079

5

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

Ganser A, Völkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D. Ganser A, et al. Blood. 1989 Jan;73(1):31-7. Blood. 1989. PMID: 2642714 Free article.

6

The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.

Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D. Ganser A, et al. Ann Intern Med. 1989 Dec 1;111(11):887-92. doi: 10.7326/0003-4819-111-11-887. Ann Intern Med. 1989. PMID: 2683920

7

Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.

Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Hess U, Elsner S, Reutzel R, Wörmann B, et al. Ganser A, et al. Leukemia. 1994 Mar;8(3):369-75. Leukemia. 1994. PMID: 7510354 Clinical Trial.

8

Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients.

Geissler RG, Muth J, Maurer A, Mentzel U, Mag M, Engels JW, Hoelzer D, Ganser A. Geissler RG, et al. Among authors: ganser a. Ann Hematol. 1995 Aug;71(2):89-95. doi: 10.1007/BF01699252. Ann Hematol. 1995. PMID: 7544629

9

Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results.

Ganser A, Heil G, Kolbe K, Maschmeyer G, Fischer JT, Bergmann L, Mitrou PS, Heit W, Heimpel H, Huber C, et al. Ganser A, et al. Ann Hematol. 1993 Mar;66(3):123-5. doi: 10.1007/BF01697620. Ann Hematol. 1993. PMID: 7682447 Clinical Trial.

10

Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot study.

Ottmann OG, Ganser A, Freund M, Heil G, Hiddemann W, Heit W, Gracien E, Hoelzer D. Ottmann OG, et al. Among authors: ganser a. Ann Hematol. 1993 Oct;67(4):161-7. doi: 10.1007/BF01695862. Ann Hematol. 1993. PMID: 7692982 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

886 results

Search Page

Filters